Endocrine Disorders: Evaluation and Management

  • Author: Todd T. Brown, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 11/14/16 (What's New)

Summary

  • American Diabetes Association recommends that patients with diabetes achieve a hemoglobin A1c of around or below 7% (Management Guidelines)[ADA Guidelines]
  • Because of the inaccuracy of hemoglobin A1c in HIV-infected patients,[Diop 2006; Kim 2009] a lower target for glycemic control, such as 6.5%, is reasonable if the patient is not experiencing significant hypoglycemia
  • Glycemic monitoring should be performed every 3-4 months, and patients should be aware of their results and the treatment goals

Action required

Keywords: Diabetes, Endocrine Disorders

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.